PairBook
HomeGPAT › GPAT vs MRNA

GPAT vs MRNA: Correlation

Measured on weekly returns over the past three years, GP-Act III Acquisition Corp. - Class A (GPAT) and Moderna (MRNA) carry a correlation of -0.32, a negative link.

Data as of 2026-08-27 · refreshed every trading day · weekly returns · methodology

Correlation (3Y)
-0.32
negative
Correlation (1Y)
-0.42
last 12 months
Correlation (5Y)
n/a
long-run
Ann. covariance
-113.2
%² · weekly, annualized

How correlated are GPAT and MRNA?

Over the past 3 years, GPAT and MRNA moved with a correlation of -0.32, which is negative, meaning they tend to move in opposite directions. Recent behaviour matches the longer record: -0.42 over 1 year against -0.32 over 3. Over 5 years the correlation is n/a, and the annualized covariance of weekly returns is -113.2 %².

Out of 22 assets tracked against GPAT, MRNA lands near the bottom at #20. Their recent paths diverged sharply: over the last 12 months MRNA outperformed by 465.4 percentage points (+3.4% for GPAT against +468.8% for MRNA). One caveat on sizing: MRNA is 31.5 times as volatile as the other leg, so an equal-dollar split is far from equal-risk.

How is this computed?

Pearson correlation on weekly returns: ρ(A,B) = cov(rA, rB) / (σA · σB), over windows of 52, 156 and 260 weeks. Covariance is annualized (×52) and expressed in %². Full definitions on the methodology page.

GPAT vs MRNA: side by side

GPAT (GP-Act III Acquisition Corp. - Class A)MRNA (Moderna)
1-year return+3.4%+468.8%
5-year returnn/a-61.5%
Volatility (ann.)3.2%100.7%
Beta vs S&P 5000.050.98
Max drawdown (3Y)-2.1%-86.6%
Market cap$0.2B$57.0B
P/E (trailing)44.6
Dividend yield0.00%0.00%
Sector / categoryUS ListedHealth Care
Smaller drawdown: GPAT -2.1% vs -86.6%
-6%0%+477%2025-09-052026-08-27
Price paths over the last 12 months, both indexed to 100 at the start (weekly closes). GPAT · MRNA

Year-by-year returns

YearGPATMRNA
2022-29.3%
2023-44.6%
2024-58.2%
2025+5.4%-29.1%
2026+2.2%+384.1%

Calendar-year price returns; the current year is year-to-date as of the data date above.

Are GPAT and MRNA good diversifiers for each other?

Yes: at -0.32, the two have gone their own ways historically, which is what genuine diversification looks like.

FAQ

What is the correlation between GPAT and MRNA?

As of 2026-08-27, the correlation of weekly returns between GPAT and MRNA is -0.32 over 3 years, -0.42 over 1 year and n/a over 5 years.

Is MRNA a good diversifier for GPAT?

Yes: at -0.32, the two have gone their own ways historically, which is what genuine diversification looks like.

What does a correlation of -0.32 mean?

A reading of -0.32 sits on a scale from −1 (opposite moves) through 0 (unrelated) to +1 (identical moves). Correlation captures direction, not magnitude or performance.

Use this data

JSON API · no key required
$ curl https://www.pairbook.io/api/v1/pairs/gpat-vs-mrna.json

GPAT vs MRNA: 3-year weekly correlation -0.32GPAT vs MRNA-0.32

Markdown for the live badge, attribution link included:

[![GPAT vs MRNA correlation](https://www.pairbook.io/api/v1/badge/gpat-vs-mrna.svg)](https://www.pairbook.io/pair/gpat-vs-mrna/)

No key needed, free to use. Full endpoint list in the API documentation.

Related comparisons

Hubs: GPAT correlations · MRNA correlations